MENU
BHVN
AS OF
Dec 24 closing price
Price
$10.81
Change
+$0.31 (+2.95%)
Capitalization
1.43B
83 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
BHVN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Biohaven (BHVN) Ownership - Who owns Biohaven?

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.43B
P/E Ratio
N/A
Total Cash
260.22M
Projected Growth
N/A
Total Debt
314.18M
Revenue
N/A
Risk (Beta)
1.89
Dividend Yield
N/A
Total Cash/Share
1.96
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BHVN
Capitalization
1.43B
P/E Ratio
N/A
Risk (Beta)
1.89
Dividend Yield
N/A
Total Cash
260M
Total Cash/Share
1.96
Total Debt
314M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-17.16M
P/B Ratio
6.49
Cash Flow
N/A
Earnings
-7.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.74B
Current Ratio
2.86
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-782.76M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-169.65
Shares Held By Institutions
1.93B
Shares Outstanding - Current
133M
Total Liabilities
426M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-71.058
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BHVN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BHVN showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for BHVN
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com